- Pfizer Abandons Obesity Pill After Liver Injury in Setback Bloomberg.com
- Pfizer scraps daily weight loss pill after liver injury in one patient CNBC
- Pfizer discontinues its experimental GLP-1 pill statnews.com
- Pfizer discontinues GLP-1 pill trial, stock trades flat Yahoo Finance
- Pfizer to halt development of closely watched weight-loss drug Financial Times